NASDAQ:ENTX | Cash Flow Statement | Entera Bio Ltd.

Complete source-backed cash-flow history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$7.31M
2026-03-31-$3.51M-$3.09M$0.00$0.00$130,000.00
2025-12-31-$3.02M-$1.83M$27,000.00-$27,000.00$174,000.00
2025-09-30-$3.2M
2025-06-30-$2.66M
2025-03-31-$2.57M-$1.4M$8,000.00-$8,000.00$13.34M
2024-12-31-$2.36M-$1.47M$3,000.00-$3,000.00$3.22M
2024-09-30-$3.02M
2024-06-30-$2.15M
2024-03-31-$2.02M-$1.86M$0.00$0.00$30,000.00
2023-12-31-$2M-$2.62M$5,000.00-$5,000.00$6.03M
2023-09-30-$2.38M
2023-06-30-$2.33M
2023-03-31-$2.19M-$1.61M$11,000.00-$11,000.00$0.00
2022-12-31-$3.04M-$2.01M$3,000.00-$3,000.00$0.00
2022-09-30-$3.07M
2022-06-30-$3.19M
2022-03-31-$3.78M-$4.79M$23,000.00-$23,000.00$0.00
2021-12-31-$4.1M-$2.51M$10,000.00-$10,000.00$21,000.00
2021-09-30-$3.21M
2021-06-30-$2.58M
2021-03-31-$2.3M-$2.32M$0.00$0.00$10.11M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$11.44M-$7.37M$107,000.00-$107,000.00$13.71M
2024-12-31-$9.54M-$6.82M$3,000.00-$3,000.00$4.48M
2023-12-31-$8.89M-$7.31M$17,000.00-$17,000.00$6.04M
2022-12-31-$13.07M-$12.5M$47,000.00-$102,000.00$13,000.00
2021-12-31-$12.19M-$9.06M$17,000.00-$17,000.00$25.38M
2020-12-31-$11.22M-$10.56M$53,000.00-$53,000.00$4.05M